Autoantibodies against autologus tumor‐associated antigens have been detected in the
asymptomatic stage of cancer and can thus serve as biomarkers for early cancer diagnosis …

Current diagnostic techniques used for the early detection of cancers are successful but
subject to detection bias. A recent focus lies in the development of more accurate diagnostic …

Autoantibodies, a hallmark of both autoimmunity and cancer, represent an easily accessible
surrogate for measuring adaptive immune responses to cancer. Sera can now be assayed …

New biomarkers are urgently needed to accelerate efforts in developing new drugs and
treatments of known diseases. New clinical and translational proteomics studies emerge …

Autoantibodies are well known as potentially highly harmful antibodies which attack the host
via binding to self-antigens, thus causing severe associated diseases and symptoms (eg …

Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor of the
digestive system worldwide, especially in China. Due to the lack of effective early detection …

Sjögren's syndrome (SS) is a chronic, progressive autoimmune disease primarily affecting
women. Diagnosis of SS requires an invasive salivary gland tissue biopsy and a long delay …

In the process of tumorigenesis, normal cells are remodeled to cancer cells and protein
expression patterns are changed to those of tumor cells. A newly formed tumor …

New therapeutic strategies are needed for malignant pleural mesothelioma (MPM). We
conducted a single-center, open-label, nonrandomized, pilot and feasibility trial using two …

Abstract Objectives Tumor‐associated autoantibodies (AAbs) in individuals with cancer can
precede clinical diagnosis by several months to years. The objective of this study was to …